Enliven Therapeutics, Inc. - Common Stock (ELVN)

$17.49 0.12 (0.69%)
16:00 EDT ELVN Stock Quote Delayed 30 Minutes

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q4 2023

By InvestorPlace Earnings
ELVN stock results show that Enliven Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

7 A-Rated Biotech Stocks for Your August Buy List

7 Biotech Stocks Sitting in the Sweet Spot

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap -
PE Ratio -
EPS -
Volume (Avg. Vol.) 221,584
Day's Range $17.15 - $17.99
52-Week Range $9.80 - $26.00
Dividend & Yield N/A (N/A)